SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S S Kenderian, M Ruella, O Shestova, M Klichinsky, V Aikawa, J J D Morrissette, J Scholler, D Song, D L Porter, M Carroll, C H June, S Gill, CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia, Leukemia, 2015, 29, 8, 1637

    CrossRef

  2. 2
    Heidi D. Klepin, Elderly Acute Myeloid Leukemia: Assessing Risk, Current Hematologic Malignancy Reports, 2015, 10, 2, 118

    CrossRef

  3. 3
    G. Ossenkoppele, B. Lowenberg, How I treat the older patient with acute myeloid leukemia, Blood, 2015, 125, 5, 767

    CrossRef

  4. 4
    Mary-Elizabeth M. Percival, Li Tao, Bruno C. Medeiros, Christina A. Clarke, Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis, Cancer, 2015, 121, 12
  5. 5
    F. Buccisano, L. Maurillo, A. Piciocchi, M. I. Del Principe, C. Sarlo, M. Cefalo, C. Ditto, A. Di Veroli, G. De Santis, M. Irno Consalvo, D. Fraboni, P. Panetta, P. Palomba, C. Attrotto, G. Del Poeta, G. Sconocchia, F. Lo-Coco, S. Amadori, A. Venditti, Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients, Annals of Hematology, 2015, 94, 8, 1319

    CrossRef

  6. 6
    Laura C. Michaelis, Harry P. Erba, Recent developments in the treatment of older individuals with acute myeloid leukemia, Current Opinion in Hematology, 2015, 22, 2, 108

    CrossRef

  7. 7
    Talha Badar, Farhad Ravandi, Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome, Clinical Lymphoma Myeloma and Leukemia, 2015, 15, S104

    CrossRef

  8. 8
    Jose J.G. Marin, Oscar Briz, Gabriela Rodríguez-Macias, José L. Díez-Martín, Rocio I.R. Macias, Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia, Blood Reviews, 2015,

    CrossRef

  9. 9
    Benedito A Carneiro, Jessica K Altman, Jason B Kaplan, Gert Ossenkoppele, Ronan Swords, Leonidas C Platanias, Francis J Giles, Targeted therapy of acute myeloid leukemia, Expert Review of Anticancer Therapy, 2015, 15, 4, 399

    CrossRef

  10. 10
    A G Dinmohamed, O Visser, Y van Norden, N M A Blijlevens, J J Cornelissen, G A Huls, P C Huijgens, P Sonneveld, A A van de Loosdrecht, G J Ossenkoppele, B Löwenberg, M Jongen-Lavrencic, Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012, Leukemia, 2015,

    CrossRef

  11. 11
    Latha Ramireddy, Chien-Yu Lin, Su-Ching Liu, Wan-Yu Lo, Rouh-Mei Hu, Yi-Chin Peng, Ching-Tien Peng, Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan, Cell Biochemistry and Biophysics, 2014, 70, 2, 1159

    CrossRef

  12. 12
    Santhosh K. Sadashiv, Christie Hilton, Cyrus Khan, James M. Rossetti, Heather L. Benjamin, Salman Fazal, Entezam Sahovic, Richard K. Shadduck, John Lister, Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia, Cancer Medicine, 2014, 3, 6
  13. 13
    H. D. Klepin, Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia, Hematology, 2014, 2014, 1, 8

    CrossRef

  14. 14
    Binay Kumar Shah, Krishna Bilas Ghimire, Improved survival among older acute myeloid leukemia patients – a population-based study, Acta Oncologica, 2014, 53, 7, 935

    CrossRef

  15. 15
    Andrew M. Brunner, Traci M. Blonquist, Hossein Sadrzadeh, Ashley M. Perry, Eyal C. Attar, Philip C. Amrein, Karen K. Ballen, Yi-Bin Chen, Donna S. Neuberg, Amir T. Fathi, Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis, Leukemia Research, 2014, 38, 7, 773

    CrossRef

  16. 16
    Felicetto Ferrara, Piera Angelillo, Antonella Carbone, Cira Riccardi, Is chemotherapy really the best option in older adults with acute myeloid leukemia?, International Journal of Hematologic Oncology, 2013, 2, 5, 355

    CrossRef

  17. 17
    Wolfgang Zimmermann, Überlebensraten älterer AML-Patienten, Im Focus Onkologie, 2013, 16, 10, 20

    CrossRef